Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Immune Regulation Announces Positive Results from Phase 1 Clinical Trial of PIN201104

b3cnewswireNovember 26, 2018

Tag: ‘1104 , immune-resetting therapies , Biopharmaceutical , ‘1104

PharmaSources Customer Service